429
Views
8
CrossRef citations to date
0
Altmetric
Articles

Synthesis of novel pyrimidine thioglycosides as structural analogs of favipiravir (avigan) and their antibird flu virus activity

, &
Pages 336-356 | Received 05 Nov 2020, Accepted 04 Jan 2021, Published online: 22 Jan 2021

References

  • Galmarini, C. M.; Jordheim, L.; Dumontet, C. Pyrimidine Nucleoside Analogs in Cancer Treatment. Exp. Rev. Anticancer Ther. 2003, 3, 717–728. DOI: 10.1586/14737140.3.5.717.
  • Elgemeie, G. H.; Abu-Zaied, M. A.; Mossa, A. H. Novel Synthesis and Biological Evaluation of the First Pyrazole Thioglycosides as Pyrazofurin Analogues. Nucleosides Nucleotides Nucleic Acids. 2019, 38, 183–202. DOI: 10.1080/15257770.2018.1508693.
  • Tozkoparan, B.; Ertan, M.; Kelicen, P.; Demirdamar, R. Synthesis and Anti-Inflammatory Activities of Some Thiazolo[3,2-a]Pyrimidine Derivatives. II Farmaco 1999, 54, 588–593. DOI: 10.1016/S0014-827X(99)00068-3.
  • Kumar, D.; Khan, S. I.; Tekwani, B. L.; Ponnan, P.; Rawat, D. S. 4-Aminoquinoline-Pyrimidine Hybrids: Synthesis, Antimalarial Activity, Heme Binding and Docking Studies. Eur. J. Med. Chem. 2015, 89, 490–502. DOI: 10.1016/j.ejmech.2014.10.061.
  • Xu, X.; Wang, J.; Yao, Q. Synthesis and Quantitative Structure-Activity Relationship (QSAR) Analysis of Some Novel Oxadiazolo[3,4-d]pyrimidine Nucleosides Derivatives as Antiviral Agents. Bioorg. Med. Chem. Lett. 2015, 25, 241–244. DOI: 10.1016/j.bmcl.2014.11.065.
  • Singh, J.; Chhikara, B. S. Comparative Global Epidemiology of HIV Infections and Status of Current Progress in Treatment. Chem. Biol. Lett. 2014, 1, 14–32.
  • Wang, M.; Cao, R.; Zhang, L.; Yang, X.; Liu, J.; Xu, M.; Shi, Z.; Hu, Z.; Zhong, W.; Xiao, G. Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro. Cell Res. 2020, 30, 269–271. DOI: 10.1038/s41422-020-0282-0.
  • Bhupender, S.; Chhikara, B. R.; Jyoti, S. P. Corona Virus SARS-CoV-2 Disease COVID-19: Infection, Prevention and Clinical Advances of the Prospective Chemical Drug Therapeutics. Chem. Biol. Lett. 2020, 7, 63–72.
  • Elgemeie, G. H.; Farag, A. B.; Amin, K. M.; El-Badry, O. M.; Hassan, G. S. Design, Synthesis and Cytotoxic Evaluation of Novel Heterocyclic Thioglycosides. Med. Chem. 2014, 4, 814–820.
  • Elgemeie, G. H.; Abu-Zaied, M. A.; Nawwar, G. A. First Novel Synthesis of Triazole Thioglycosides as Ribavirin Analogues. Nucleosides. Nucleotides Nucleic Acids 2018, 37, 112–123.
  • Abu-Zaied, M. A.; Elgemeie, G. H. Thiazoles in Glycosylation Reactions: Novel Synthesis of Thiazole Thioglycosides. Heteroatom. Chem. 2017, 28, e21404. DOI: 10.1002/hc.21404.
  • Abu-Zaied, M. A.; Elgemeie, G. H. Synthesis of the First Novel Pyrazole Thioglycosides as Deaza Ribavirin Analogues. Nucleosides Nucleotides Nucleic Acids. 2017, 36, 713–725. DOI: 10.1080/15257770.2017.1378817.
  • Elgemeie, G. H.; Farag, A. B. Design, Synthesis, and in Vitro anti-Hepatocellular Carcinoma of Novel Thymine Thioglycoside Analogs as New Antimetabolic Agents. Nucleosides. Nucleotides Nucleic Acids 2017, 36, 355–377.
  • Elgemeie, G. H.; Abu-Zaied, M.; Alsaid, S.; Hebishy, A.; Essa, H. Novel Nucleoside Analogues: First Synthesis of Pyridine-4-Thioglycosides and Their Cytotoxic Evaluation. Nucleosides Nucleotides Nucleic Acids 2015, 34, 659–673.
  • Elgemeie, G. H.; Abu-Zaied, M. A.; Loutfy, S. A. 4-Aminoantipyrine in Carbohydrate Research: Design, Synthesis and Anticancer Activity of a Novel Class of Derivatives of 4-Aminoantipyrine Thioglycosides and Their Corresponding Pyrazolopyrimidine and Pyrazolopyridine Thioglycosides. Tetrahedron 2017, 73, 5853–5861; Abu-Zaied, M. A.; Loutfy, S. A.; Hassan, A. E. and Elgemeie, G. H. Novel Purine Thioglycoside Analogs: Synthesis, Nanoformulation and Biological Evaluation in In-Vitro Human Liver and Breast Cancer Models. Drug Des. Dev. Ther. 2019, 13, 2437–2457.
  • Elgemeie, G. H.; Zaghary, W. A.; Amin, K. M.; Nasr, T. M. First Synthesis of Thienopyrazole Thioglycosides. J. Carbohydr. Chem. 2008, 27, 345–356. DOI: 10.1080/07328300802236178.
  • Abu-Zaied, M. A.; El-Telbani, E. M.; Elgemeie, G. H.; Nawwar, G. A. Synthesis and In Vitro Anti-Tumor Activity of New Oxadiazole Thioglycosides. Eur. J. Med. Chem. 2011, 46, 229–235. DOI: 10.1016/j.ejmech.2010.11.008.
  • Elgemeie, G. H.; El-Enany, M. M.; Ismail, M. M.; Ahmed, E. K. Nucleic Acid Components and Their Analogues: A Novel and Efficient Method for the Synthesis of a New Class of Bipyridyl and Biheterocyclic-Nitrogen Thioglycosides from Pyridine-2(1H)-Thiones. Nucleosides Nucleotides Nucleic Acids. 2002, 21, 477–493. DOI: 10.1081/NCN-120014820.
  • Scala, S.; Akhmed, K.; Rao, U. S.; Paull, K.; Lan, L.; Dickstein, B.; Lee, J.; Elgemeie, G. H.; Stein, W. D.; Bates, S. E. P-Glycoprotein Substrates and Antagonists Cluster into Two Distinct Groups. Mol. Pharmacol. 1997, 51, 1024–1033. DOI: 10.1124/mol.51.6.1024.
  • Elgemeie, H.; Mahdy, M.; Elgawish, A.; Ahmed, M.; Shousha, G. Eldin, A New Class of Antimetabolites: Pyridine Thioglycosides as Potential Anticancer Agents. Z. Naturforsch. 2010, 65c, 577–576.
  • Abu-Zaied, M. A.; Elgemeie, G. H.; Jones, P. G. Crystal Structure of 4,6-Dimethyl-2-[(2,3,4,6-tetra-O-Acetyl-β-D-Galactopyranosyl)Sulfanyl] Pyrimidine. Acta Cryst. 2019, E75, 1820–1823.
  • Elgemeie, G. H.; Elghandour, A. H.; Elzanate, A. M.; Ahmed, S. A. Synthesis of Some Novel α-Cyanoketene S,S-Acetals and Their Use in Heterocyclic Synthesis. J. Chem. Soc. Perkin Trans. 1. 1997, 21, 3285–3290. DOI: 10.1039/a702343j.
  • Elgemeie, G. H.; Elghandour, A. H.; Abd-Elaziz, G. W. Potassium 2-Cyanoethylene-1-Thiolate Derivative: A New Preparative Route to 2-Cyanoketene S,N-Acetals and Pyrazole Derivatives. Synth. Commun. 2004, 34, 3281–3291. DOI: 10.1081/SCC-200030549.
  • Mossman, T. Rapide Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983, 65, 55–63.
  • Hayden, F. G.; Cote, K. M.; Douglas, R. G. Plaque Inhibition Assay for Drug Susceptibility Testing of Influenza Viruses. Antimicrob. Agents Chemother. 1980, 17, 865–870. DOI: 10.1128/aac.17.5.865.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.